Associate Professor, Internal Medicine, Yale University School of Medicine
Gastroenterology
Dr. Michael L. Schilsky, MD
|
|
Give Review
Michael Schilsky practices Gastroenterology. He went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He has 2 awards "Fellow American Association for the Study of Liver Disease" and "CMS Meaningful Use Stage 1 Certification". Michael Schilsky is a published physician. He published 93 publications, including: 'New knowledge of genetic pathogenesis of hemochromatosis and Wilson's disease.' Michael Schilsky accepts Medicare payments and is listed with Medicare.gov.
Publications
- Gene therapy of Wilson Disease: A "golden" opportunity using rAAV on the 50th anniversary of the discovery of the virus.
- Acute Liver Injury and Acute Liver Failure from Mushroom Poisoning in North America.
- Liver transplantation for Wilson's Disease.
- Segmental Grafts in Adult and Pediatric Liver Transplantation: Improving Outcomes by Minimizing Vascular Complications.
- Long-term Outcome for Wilson Disease: 85% good.
- Steroid use in acute liver failure.
- Hepatitis B "360".
- Pre-liver transplant protocols in dentistry.
- Transplantation for inherited metabolic Disorders of the liver.
- Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.
- Successful Treatment of a Bleeding Umbilical Varix by Percutaneous Umbilical Vein Embolization With Sclerotherapy.
- Mining for a diagnosis of Wilson's Disease in children: genetics, score, and ore.
- Liver transplantation for inherited metabolic Disorders of the liver.
- Genetic testing for Wilson Disease: availability and utility.
- Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson Disease in the Long-Evans Cinnamon rat model.
- ICU management of acute liver failure.
- Inherited metabolic Disease of the liver.
- Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson Disease.
- Diagnosis and long-term management of Wilson Disease.
- Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity.
- Inherited metabolic liver Disease.
- Wilson Disease: new insights into pathogenesis, diagnosis, and future therapy.
- Wilson Disease: pathophysiology, diagnosis, treatment, and screening.
- Wilson's Disease and hemochromatosis.
- Inherited metabolic Disease.
- Population screening for Wilson's Disease.
- 99mTc-mebrofenin scintigraphy for evaluating liver Disease in a rat model of Wilson's Disease.
- Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic Copper with reversal of liver disease.
- Genetic modifiers of liver injury in hereditary liver Disease.
- Metal storage Disorders. Forward.
- Wilson Disease: pathogenesis and clinical considerations in diagnosis and treatment.
- A clinical assessment of Wilson Disease in patients with concurrent liver Disease.
- Use of model for end-stage liver Disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature.
- Liver transplantation for children with Wilson Disease: comparison of outcomes between children and adults.
- Diagnosis and phenotypic classification of Wilson Disease.
- Zinc treatment for symptomatic Wilson Disease: moving forward by looking back.
- Soluble CD163 from activated macrophages predicts mortality in acute liver failure.
- Once daily trientine for maintenance therapy of Wilson Disease.
- Wilson disease in children: serum aminotransferases and urinary Copper on triethylene tetramine dihydrochloride (trientine) treatment.
- Treatment of Wilson Disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic...
- Thrombopoietin in acute liver failure.
- Wilson Disease in septuagenarian siblings: Raising the bar for diagnosis.
- Autonomic cardiovascular reflexes in Wilson''s Disease.
- Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes.
- Diagnosis and treatment of Wilson''s Disease.
- A practice guideline on Wilson Disease.
- Survival after liver transplantation in patients with hepatic iron overload: the national Hemochromatosis transplant registry.
- Metabolic liver Disease.
- Caeruloplasmin biosynthesis by the human uterus.
- Prognosis of Wilsonian chronic active Hepatitis.
- Detection of multiple forms of human ceruloplasmin. A novel Mr 200,000 form.
- Hepatocellular Copper toxicity and its attenuation by zinc.
- Penicillamine may detoxify Copper in Wilson''s disease.
- An array of mitochondrial alterations in the hepatocytes of Long-Evans Cinnamon rats.
- In vitro modeling of liver membrane Copper transport.
- Secretion, surface localization, turnover, and steady state expression of protein disulfide isomerase in rat hepatocytes.
- Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer.
- Identification of the Wilson's Disease gene: clues for Disease pathogenesis and the potential for molecular diagnosis.
- Liver transplantation for Wilson's Disease: indications and outcome.
- Induction of MnSOD gene expression in a hepatic model of TNF-alpha toxicity does not result in increased protein.
- Pleiotropic effect of LEC mutation: a rodent model of Wilson's Disease.
- Animal models of Copper toxicosis.
- Wilson disease: genetic basis of Copper toxicity and natural history.
- An international symposium on Wilson's and Menkes' Diseases.
- Ironic insult added to Copper injury.
- Overcoming obstacles to the diagnosis of Wilson's Disease.
- Identification of B10, an alkaline phosphodiesterase of the apical plasma membrane of hepatocytes and Biliary cells, in rat serum: increased levels following bile duct...
- ATP7B (WND) protein.
- Copper resistant human hepatoblastoma mutant cell lines without metallothionein induction overexpress ATP7B.
- Fractionation of rat hepatocyte subpopulations with varying metabolic potential, proliferative capacity, and retroviral gene transfer efficiency.
- New knowledge of genetic pathogenesis of hemochromatosis and Wilson's Disease.
- Spontaneous cholangiofibrosis in Long-Evans Cinnamon rats: a rodent model for Wilson's Disease.
- Biliary copper excretion capacity in intact animals: correlation between ATP7B function, hepatic mass, and Biliary copper excretion.
- Treatment of Wilson's Disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
- Correction of liver Disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's Disease.
- Orthotopic liver transplantation for Wilson's Disease: a single-center experience.
- The irony of treating Wilson's Disease.
- Wilson''s Disease.
- Non-invasive testing for Wilson Disease: revisiting the d-penicillamine challenge test.
- Development of cell therapy strategies to overcome Copper toxicity in the LEC rat model of Wilson disease.
- Prevalence of hepatic iron overload and association with hepatocellular Cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
- Wilson Disease: current status and the future.
- Gemcitabine-induced hepatitis in a pancreatic Cancer patient receiving adjuvant therapy following metastasectomy.
- Outcome of acute liver failure in the elderly.
- Diagnosis and treatment of Wilson Disease: an update.
- Screening for Wilson Disease in acute liver failure: a comparison of currently available diagnostic tests.
- Testing and management of thrombocytopenia and coagulopathy in the pre- and postliver transplant patient.
- Acute liver failure and liver assist devices.
- Combined liver kidney transplantation: critical analysis of a single-center experience.
- Successful treatment of fibrosing cholestatic Hepatitis after liver transplantation.
- Trientine induced colitis during therapy for Wilson Disease: a case report and review of the literature.
- Advances in liver transplantation allocation Systems.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- Fellow American Association for the Study of Liver Disease
- CMS Meaningful Use Stage 1 Certification
Education
-
Albert Einstein College of Medicine at Jacobi Medical Center -
University of Chicago Pritzker School of Medicine
Hospital
-
Greenwich Hospital -
Danbury Hospital -
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1932296027 | |
| NPPES Provider LastName | SCHILSKY | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 065103206 | |
| NPPES Provider State | CT | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 1756.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 0.91 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932296027 |
| Last Name Of The Provider | SCHILSKY |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Jack Chuong, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah D. Proctor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert M. Aaronson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafaz Hoque, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara A. Ross, MD |
|
|
Dr. Prithvi Sreenivasan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Higham-Kessler, MD |
|
|
Dr. Frederick K. Shieh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sofia S. Jakab, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley D. Hudnall, MD
This Doctor is OpenDoctor Recommended.
|